Role and sensitivity of Positron Emission Tomography with [18F] Fluorodeoxyglucose in diagnosis and follow-up of patients affected by chronic pulmonary aspergillosis (CPA)
Journal Title: Journal of Health and Social Sciences - Year 2018, Vol 3, Issue 1
Abstract
Introduction: PET/CT is considered as a powerful tool to diagnose, stage, and monitor patients with a variety of diseases. In this study, we assessed the sensitivity and the degree of agreement between 18F-FDG PET/CT and serological tests in diagnosis and follow-up of patients affected by chronic pulmonary aspergillosis (CPA). Methods: Thirty-seven adult patients (21 males and 16 females) affected by CPA were recruited during the study period (2010 - 2017). At the time of first diagnosis, we compared sensitivity of 18F-FDG PET/CT and serologic tests (i.e., identification of Aspergillus-specific IgE and IgG antibodies using IFA and ELISA). 12 months after the treatment, we repeated tests only in patients with possible active disease to make a comparison between serological tests and 18F-FDG PET/CT. Sensitivity was calculated as the proportion of positive results obtained with the index test among cases. The agreement between diagnostic techniques was assessed using the Kappa coefficient. The level of significance was set at 5% (P < 0.05). Results: At the time of first diagnosis, agreement between 18F-FDG PET/CT and serologic tests was ‘almost perfect’ (88%, Kappa = 0.846, P < 0.05), whereas it was ‘good’ at 12 months follow-up (81%, Kappa = 0.684, P < 0.05). At first diagnosis, serological test had a higher sensitivity (94.59%, 95% Confidence Interval [CI] 81.81% to 99.34%) in comparison with 18F-FDG PET/CT (83.78%, 95% CI 67.99% to 93.81%). Conversely, at 12-month follow-up, 18F-FDG PET/CT showed higher sensitivity (93.75, 95% CI 69.77% to 99.84%) than serological test group (75%, 95% CI 47.62% to 92.73%). Discussion and Conclusion: Our findings demonstrate that both methods are suitable and have almost equivalent sensitivity in diagnosis and follow-up of patients affected by CPA with active disease. 18F-FDG PET/CT scan is a reliable support tool for clinical and serological data in the diagnosis and follow-up of aspergillosis infection, providing additional information on metabolic activity, accurate anatomic localization and extent of disease.
Authors and Affiliations
Gianfranco Schiraldi, Cristina Elena Popescu, Michele Chiericozzi, Salvatore Lo Cicero, Flavio Allegri, Franco Mosca, Claudio Rossetti
Stop violence and crimes against children
Violence against children affects at least 1.6 billion children around the world every year [1]. Any adverse childhood experiences may represent potentially traumatic events with negative long-lasting impacts on the psyc...
Role of epigenetics in aetiology and therapies for Type 1 Diabetes Mellitus: A narrative review
Introduction: Abundant literature has established the negative impact of traditional media on body image and disordered eating behaviors among young women. In the past few years, social media use has soared especially am...
Towards the Universal Health Coverage in Ghana: An exploratory, cross-sectional study on the National Health Insurance Scheme
Introduction: This study is aimed to analyze the progress towards the attainment of Universal Health Coverage (UHC) in Ghana after the establishment of the ‘National Health Insurance Scheme’ (NHIS), which is a universal...
Promoting cross-culture research on moral decision-making with standardized, culturally-equivalent dilemmas: The 4CONFiDe set
Introduction: Moral dilemmas are a common tool in moral decision-making research. However, they are often hardly comparable across languages and cultures. Here, we propose a methodology to adapt, convert and test moral d...
Learning to live: The role of education policy for improving the quality of primary and preventative healthcare in the United States
From a policy standpoint, education and healthcare are often discussed separately in the United States. A review of the current literature reveals that education can be a strong predictor of individual health outcomes, i...